BioStem Technologies, Inc.
BSEM
$14.50
-$0.03-0.21%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 10.83% | 77.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.83% | 77.77% | |||
| Cost of Revenue | 13.10% | 68.47% | |||
| Gross Profit | 10.71% | 78.29% | |||
| SG&A Expenses | 10.84% | 76.81% | |||
| Depreciation & Amortization | 4.99% | 0.74% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.56% | 76.08% | |||
| Operating Income | 5.37% | 91.40% | |||
| Income Before Tax | 5.50% | 95.32% | |||
| Income Tax Expenses | 0.81% | 95.32% | |||
| Earnings from Continuing Operations | 7.20% | 95.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.20% | 95.32% | |||
| EBIT | 5.37% | 91.40% | |||
| EBITDA | 5.37% | 90.29% | |||
| EPS Basic | 7.02% | 95.59% | |||
| Normalized Basic EPS | 5.32% | 95.48% | |||
| EPS Diluted | 6.67% | 118.18% | |||
| Normalized Diluted EPS | 6.57% | 114.17% | |||
| Average Basic Shares Outstanding | 0.17% | -0.12% | |||
| Average Diluted Shares Outstanding | -1.04% | -8.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||